カテゴリー： Stratistics MRC, 世界, 医療/バイオ

結核（TB）診断の世界市場予測（～2027年）

◆英語タイトル：Tuberculosis (TB) Diagnostics Market Forecasts to 2028 – Global Analysis by Product Types (Detection of Latent Infection, Cytokine Detection Assay, Diagnostic Laboratory Methods, Other Product Types), Test Type (Tuberculin skin tests, Interferon-gamma release assays (IGRAs), Smear microscopy, Other test types), Type (Sputum Smear Microscopy, Rapid Molecular Diagnostics, Other Types), End-user (Diagnostic Laboratories, Hospitals, Other end users), and By Geography

Stratistics MRCが発行した調査報告書（SMR23MR030）◆商品コード：SMR23MR030
◆発行会社（リサーチ会社）：Stratistics MRC
◆発行日：2022年10月
◆ページ数：約150
◆レポート形式：英語 / Eメール
◆納品方法：英語
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Global Site LicenseUSD4,150 ⇒換算￥630,800見積依頼/購入/質問フォーム
PDFUSD7,500 ⇒換算￥1,140,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）

❖ レポートの概要 ❖

ストラティスティックスMRC社は、世界の結核（TB）診断市場規模が2022年18.4億ドルから2028年29.4億ドルになり、予測期間中に年平均8.1%で成長すると予測しています。本報告書では、結核（TB）診断の世界市場を調査し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、製品種類別（潜在感染検出、サイトカイン検出アッセイ、診断検査法、その他）分析、検査種類別（ツベルクリン皮膚検査、インターフェロンガンマ放出アッセイ（IGRA）分析、塗抹顕微鏡、その他）分析、種類別（喀痰塗抹顕微鏡、迅速分子診断、その他）分析、エンドユーザー別（診断研究所、病院、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ）分析、最近の動向、企業情報など、次のように掲載しています。また、企業情報としては、Becton, Dickinson and Company, Abbott Laboratories, Siemens, Hologic Corporation, Cepheid, BioMérieux SA, Hain Life sciences GmBH, F.Hoffmann-La Roche AG, Alere, Inc., F. Hoffmann-La Roche Ltd (Switzerland)などが含まれています。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・世界の結核（TB）診断市場規模：製品種類別
- 潜在感染検出の市場規模
- サイトカイン検出アッセイの市場規模
- 診断検査法の市場規模
- その他製品の市場規模
・世界の結核（TB）診断市場規模：検査種類別
- ツベルクリン皮膚検査の市場規模
- インターフェロンガンマ放出アッセイ（IGRA）の市場規模
- 塗抹顕微鏡の市場規模
- その他検査の市場規模
・世界の結核（TB）診断市場規模：種類別
- 喀痰塗抹顕微鏡の市場規模
- 迅速分子診断の市場規模
- その他種類の市場規模
・世界の結核（TB）診断市場規模：エンドユーザー別
- 診断研究所における市場規模
- 病院における市場規模
- その他エンドユーザーにおける市場規模
・世界の結核（TB）診断市場規模：地域別
- 北米の結核（TB）診断市場規模
- ヨーロッパの結核（TB）診断市場規模
- アジア太平洋の結核（TB）診断市場規模
- 南米の結核（TB）診断市場規模
- 中東・アフリカの結核（TB）診断市場規模
・最近の動向
・企業情報

According to Stratistics MRC, the Global Tuberculosis (TB) Diagnostics Market is accounted for $1.84 billion in 2022 and is expected to reach $2.94 billion by 2028 growing at a CAGR of 8.1% during the forecast period. Mycobacterium tuberculosis is a type of bacteria that causes the dangerous disease tuberculosis. The patient’s lungs are typically the target of the illness. The infection can also affect the spine and the brain, among other bodily parts. Skin testing and blood tests can be used to diagnose tuberculosis. The necessity for precise and effective diagnostic tests to stop the spread of this condition has increased as its incidence has increased. In the upcoming years, it is anticipated that this factor will dramatically increase demand for tuberculosis tests.

According to the Global Tuberculosis Report 2021 published by the World Health Organization, in October 2021, most of the tuberculosis cases were found in the World Health Organization (WHO) regions of South-East Asia (43%), Africa (25%), and the Western Pacific (18%), and lesser numbers of tuberculosis cases were found in Eastern Mediterranean (8.3%), and Europe (2.3%). According to the data published by the World Health Organization (WHO), in October 2021, about 1.5 million people worldwide died because of tuberculosis (TB), in 2020, and approximately 10 million people fell ill with tuberculosis globally.

Key players in the market

Some of the key players in Tuberculosis (TB) Diagnostics market include Becton, Dickinson and Company, Abbott Laboratories, Siemens, Hologic Corporation, Cepheid, BioMérieux SA, Hain Life sciences GmBH, F.Hoffmann-La Roche AG, Alere, Inc., F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Netherlands), Hain Life science GmbH, Oxford Immunotec USA, Inc., Akonni Biosystems, Inc., Epistem Ltd., Johnson & Johnson Services, Inc., Novartis AG, GlaxoSmithKline PLC, PerkinElmer Inc.

Key Developments:

In May 2022, F. Hoffmann-La Roche Ltd entered into a partnership with the Global Fund to support low and middle-income countries in strengthening critical diagnosis infrastructure against infectious diseases.

In March 2022, Thermo Fisher Scientific Inc. launched the SeqStudio Flex Series Genetic Analyzer for research and development of infectious disease detection, which is expected to expand the company’s product portfolio in the market.

In February 2022, QIAGEN announced that its Quanti FERON tuberculosis testing solution received the approval of the fourth generation of a modern gold standard test in China.

In July 2021, F. Hoffmann-La Roche Ltd. announced that WHO included the company’s products cobas MTB and cobas MTB-RIF/INH tests as Nucleic Acid Amplification Tests Go (NAATs). These products are nucleic acid testing products used to detect tuberculosis and drug resistance TB.

In March 2021, Hologic, Inc. announced the CE marking of its tuberculosis (TB) IGRA test on VIDAS. VIDAS TB-IGRA is an automated assay that helps in the diagnosis of infection with Mycobacterium tuberculosis.

Products Covered:
• Detection of Latent Infection
• Cytokine Detection Assay
• Diagnostic Laboratory Methods
• Nucleic Acid Testing
• Detection of Drug Resistance
• Radiographic Method
• Other Product Types

Test Types Covered:
• Wet Tuberculin skin tests
• Interferon-gamma release assays (IGRAs)
• Smear microscopy
• Serological antibody-based tests
• Culture
• Identification or speciation tests
• Nucleic acid amplification tests (NAATs)
• Phenotypic drug susceptibility tests
• Adenosine deaminase (ADA) test.

Types Covered:
• Sputum Smear Microscopy
• Rapid Molecular Diagnostics
• Culture-based Diagnostics
• Other Types

End Users Covered:
• Diagnostic Laboratories
• Hospitals
• Clinics
• Reference Laboratories
• Research Institutes and Academics
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

❖ レポートの目次 ❖

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Tuberculosis (TB) Diagnostics Market, By Product
5.1 Introduction
5.2 Detection of Latent Infection
5.3 Cytokine Detection Assay
5.4 Diagnostic Laboratory Methods
5.5 Nucleic Acid Testing
5.6 Detection of Drug Resistance
5.7 Radiographic Method
5.8 Other Products
6 Global Tuberculosis (TB) Diagnostics Market, By Test Type
6.1 Introduction
6.2 Tuberculin Skin Tests
6.3 Interferon-Gamma Release Assays (IGRAs)
6.4 Smear Microscopy
6.5 Serological Antibody-Based Tests
6.6 Culture
6.7 Identification or Speciation Tests
6.8 Nucleic Acid Amplification Tests (NAATs)
6.9 Phenotypic Drug Susceptibility Tests
6.10 Adenosine Deaminase (ADA) Test
7 Global Tuberculosis (TB) Diagnostics Market, By Type
7.1 Introduction
7.2 Sputum Smear Microscopy
7.3 Rapid Molecular Diagnostics
7.4 Culture-based Diagnostics
7.5 Other Types
8 Global Tuberculosis (TB) Diagnostics Market, By End User
8.1 Introduction
8.2 Diagnostic Laboratories
8.3 Hospitals
8.3.1 Public
8.3.2 Private
8.4 Clinics
8.5 Reference Laboratories
8.6 Research Institutes and Academics
8.7 Other End Users
9 Global Tuberculosis (TB) Diagnostics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Becton, Dickinson and Company
11.2 Abbott Laboratories
11.3 Siemens
11.4 Hologic Corporation
11.5 Cepheid
11.6 bioMérieux SA
11.7 Hain Lifesciences GmBH
11.8 F.Hoffmann-La Roche AG
11.9 Alere, Inc.
11.10 F. Hoffmann-La Roche Ltd (Switzerland)
11.11 Thermo Fisher Scientific Inc. (U.S.)
11.12 QIAGEN (Netherlands)
11.13 Hain Lifescience GmbH
11.14 Oxford Immunotec USA, Inc.
11.15 Akonni Biosystems, Inc.
11.16 EpistemLtd.
11.17 Johnson & Johnson Services, Inc.
11.18 Novartis AG
11.19 GlaxoSmithKline PLC
11.20 PerkinElmer Inc.
List of Tables
Table 1 Global Tuberculosis (TB) Diagnostics Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Tuberculosis (TB) Diagnostics Market Outlook, By Product Types (2020-2028) ($MN)
Table 3 Global Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Latent Infection (2020-2028) ($MN)
Table 4 Global Tuberculosis (TB) Diagnostics Market Outlook, By Cytokine Detection Assay (2020-2028) ($MN)
Table 5 Global Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratory Methods (2020-2028) ($MN)
Table 6 Global Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Testing (2020-2028) ($MN)
Table 7 Global Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Drug Resistance (2020-2028) ($MN)
Table 8 Global Tuberculosis (TB) Diagnostics Market Outlook, By Radiographic Method (2020-2028) ($MN)
Table 9 Global Tuberculosis (TB) Diagnostics Market Outlook, By Other Products (2020-2028) ($MN)
Table 10 Global Tuberculosis (TB) Diagnostics Market Outlook, By Test Type (2020-2028) ($MN)
Table 11 Global Tuberculosis (TB) Diagnostics Market Outlook, By Tuberculin Skin Tests (2020-2028) ($MN)
Table 12 Global Tuberculosis (TB) Diagnostics Market Outlook, By Interferon-Gamma Release Assays (IGRAs) (2020-2028) ($MN)
Table 13 Global Tuberculosis (TB) Diagnostics Market Outlook, By Smear Microscopy (2020-2028) ($MN)
Table 14 Global Tuberculosis (TB) Diagnostics Market Outlook, By Serological Antibody-Based Tests (2020-2028) ($MN)
Table 15 Global Tuberculosis (TB) Diagnostics Market Outlook, By Culture (2020-2028) ($MN)
Table 16 Global Tuberculosis (TB) Diagnostics Market Outlook, By Identification or Speciation Tests (2020-2028) ($MN)
Table 17 Global Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Amplification Tests (NAATs) (2020-2028) ($MN)
Table 18 Global Tuberculosis (TB) Diagnostics Market Outlook, By Phenotypic Drug Susceptibility Tests (2020-2028) ($MN)
Table 19 Global Tuberculosis (TB) Diagnostics Market Outlook, By Adenosine Deaminase (ADA) Test (2020-2028) ($MN)
Table 20 Global Tuberculosis (TB) Diagnostics Market Outlook, By Type (2020-2028) ($MN)
Table 21 Global Tuberculosis (TB) Diagnostics Market Outlook, By Sputum Smear Microscopy (2020-2028) ($MN)
Table 22 Global Tuberculosis (TB) Diagnostics Market Outlook, By Rapid Molecular Diagnostics (2020-2028) ($MN)
Table 23 Global Tuberculosis (TB) Diagnostics Market Outlook, By Culture-based Diagnostics (2020-2028) ($MN)
Table 24 Global Tuberculosis (TB) Diagnostics Market Outlook, By Other Types (2020-2028) ($MN)
Table 25 Global Tuberculosis (TB) Diagnostics Market Outlook, By End User (2020-2028) ($MN)
Table 26 Global Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratories (2020-2028) ($MN)
Table 27 Global Tuberculosis (TB) Diagnostics Market Outlook, By Hospitals (2020-2028) ($MN)
Table 28 Global Tuberculosis (TB) Diagnostics Market Outlook, By Public (2020-2028) ($MN)
Table 29 Global Tuberculosis (TB) Diagnostics Market Outlook, By Private (2020-2028) ($MN)
Table 30 Global Tuberculosis (TB) Diagnostics Market Outlook, By Clinics (2020-2028) ($MN)
Table 31 Global Tuberculosis (TB) Diagnostics Market Outlook, By Reference Laboratories (2020-2028) ($MN)
Table 32 Global Tuberculosis (TB) Diagnostics Market Outlook, By Research Institutes and Academics (2020-2028) ($MN)
Table 33 Global Tuberculosis (TB) Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 34 North America Tuberculosis (TB) Diagnostics Market Outlook, By Country (2020-2028) ($MN)
Table 35 North America Tuberculosis (TB) Diagnostics Market Outlook, By Product Types (2020-2028) ($MN)
Table 36 North America Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Latent Infection (2020-2028) ($MN)
Table 37 North America Tuberculosis (TB) Diagnostics Market Outlook, By Cytokine Detection Assay (2020-2028) ($MN)
Table 38 North America Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratory Methods (2020-2028) ($MN)
Table 39 North America Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Testing (2020-2028) ($MN)
Table 40 North America Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Drug Resistance (2020-2028) ($MN)
Table 41 North America Tuberculosis (TB) Diagnostics Market Outlook, By Radiographic Method (2020-2028) ($MN)
Table 42 North America Tuberculosis (TB) Diagnostics Market Outlook, By Other Products (2020-2028) ($MN)
Table 43 North America Tuberculosis (TB) Diagnostics Market Outlook, By Test Type (2020-2028) ($MN)
Table 44 North America Tuberculosis (TB) Diagnostics Market Outlook, By Tuberculin Skin Tests (2020-2028) ($MN)
Table 45 North America Tuberculosis (TB) Diagnostics Market Outlook, By Interferon-Gamma Release Assays (IGRAs) (2020-2028) ($MN)
Table 46 North America Tuberculosis (TB) Diagnostics Market Outlook, By Smear Microscopy (2020-2028) ($MN)
Table 47 North America Tuberculosis (TB) Diagnostics Market Outlook, By Serological Antibody-Based Tests (2020-2028) ($MN)
Table 48 North America Tuberculosis (TB) Diagnostics Market Outlook, By Culture (2020-2028) ($MN)
Table 49 North America Tuberculosis (TB) Diagnostics Market Outlook, By Identification or Speciation Tests (2020-2028) ($MN)
Table 50 North America Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Amplification Tests (NAATs) (2020-2028) ($MN)
Table 51 North America Tuberculosis (TB) Diagnostics Market Outlook, By Phenotypic Drug Susceptibility Tests (2020-2028) ($MN)
Table 52 North America Tuberculosis (TB) Diagnostics Market Outlook, By Adenosine Deaminase (ADA) Test (2020-2028) ($MN)
Table 53 North America Tuberculosis (TB) Diagnostics Market Outlook, By Type (2020-2028) ($MN)
Table 54 North America Tuberculosis (TB) Diagnostics Market Outlook, By Sputum Smear Microscopy (2020-2028) ($MN)
Table 55 North America Tuberculosis (TB) Diagnostics Market Outlook, By Rapid Molecular Diagnostics (2020-2028) ($MN)
Table 56 North America Tuberculosis (TB) Diagnostics Market Outlook, By Culture-based Diagnostics (2020-2028) ($MN)
Table 57 North America Tuberculosis (TB) Diagnostics Market Outlook, By Other Types (2020-2028) ($MN)
Table 58 North America Tuberculosis (TB) Diagnostics Market Outlook, By End User (2020-2028) ($MN)
Table 59 North America Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratories (2020-2028) ($MN)
Table 60 North America Tuberculosis (TB) Diagnostics Market Outlook, By Hospitals (2020-2028) ($MN)
Table 61 North America Tuberculosis (TB) Diagnostics Market Outlook, By Public (2020-2028) ($MN)
Table 62 North America Tuberculosis (TB) Diagnostics Market Outlook, By Private (2020-2028) ($MN)
Table 63 North America Tuberculosis (TB) Diagnostics Market Outlook, By Clinics (2020-2028) ($MN)
Table 64 North America Tuberculosis (TB) Diagnostics Market Outlook, By Reference Laboratories (2020-2028) ($MN)
Table 65 North America Tuberculosis (TB) Diagnostics Market Outlook, By Research Institutes and Academics (2020-2028) ($MN)
Table 66 North America Tuberculosis (TB) Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 67 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Country (2020-2028) ($MN)
Table 68 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Product Types (2020-2028) ($MN)
Table 69 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Latent Infection (2020-2028) ($MN)
Table 70 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Cytokine Detection Assay (2020-2028) ($MN)
Table 71 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratory Methods (2020-2028) ($MN)
Table 72 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Testing (2020-2028) ($MN)
Table 73 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Drug Resistance (2020-2028) ($MN)
Table 74 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Radiographic Method (2020-2028) ($MN)
Table 75 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Other Products (2020-2028) ($MN)
Table 76 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Test Type (2020-2028) ($MN)
Table 77 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Tuberculin Skin Tests (2020-2028) ($MN)
Table 78 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Interferon-Gamma Release Assays (IGRAs) (2020-2028) ($MN)
Table 79 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Smear Microscopy (2020-2028) ($MN)
Table 80 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Serological Antibody-Based Tests (2020-2028) ($MN)
Table 81 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Culture (2020-2028) ($MN)
Table 82 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Identification or Speciation Tests (2020-2028) ($MN)
Table 83 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Amplification Tests (NAATs) (2020-2028) ($MN)
Table 84 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Phenotypic Drug Susceptibility Tests (2020-2028) ($MN)
Table 85 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Adenosine Deaminase (ADA) Test (2020-2028) ($MN)
Table 86 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Type (2020-2028) ($MN)
Table 87 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Sputum Smear Microscopy (2020-2028) ($MN)
Table 88 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Rapid Molecular Diagnostics (2020-2028) ($MN)
Table 89 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Culture-based Diagnostics (2020-2028) ($MN)
Table 90 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Other Types (2020-2028) ($MN)
Table 91 Europe Tuberculosis (TB) Diagnostics Market Outlook, By End User (2020-2028) ($MN)
Table 92 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratories (2020-2028) ($MN)
Table 93 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Hospitals (2020-2028) ($MN)
Table 94 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Public (2020-2028) ($MN)
Table 95 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Private (2020-2028) ($MN)
Table 96 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Clinics (2020-2028) ($MN)
Table 97 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Reference Laboratories (2020-2028) ($MN)
Table 98 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Research Institutes and Academics (2020-2028) ($MN)
Table 99 Europe Tuberculosis (TB) Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 100 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Country (2020-2028) ($MN)
Table 101 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Product Types (2020-2028) ($MN)
Table 102 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Latent Infection (2020-2028) ($MN)
Table 103 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Cytokine Detection Assay (2020-2028) ($MN)
Table 104 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratory Methods (2020-2028) ($MN)
Table 105 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Testing (2020-2028) ($MN)
Table 106 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Drug Resistance (2020-2028) ($MN)
Table 107 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Radiographic Method (2020-2028) ($MN)
Table 108 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Other Products (2020-2028) ($MN)
Table 109 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Test Type (2020-2028) ($MN)
Table 110 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Tuberculin Skin Tests (2020-2028) ($MN)
Table 111 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Interferon-Gamma Release Assays (IGRAs) (2020-2028) ($MN)
Table 112 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Smear Microscopy (2020-2028) ($MN)
Table 113 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Serological Antibody-Based Tests (2020-2028) ($MN)
Table 114 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Culture (2020-2028) ($MN)
Table 115 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Identification or Speciation Tests (2020-2028) ($MN)
Table 116 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Amplification Tests (NAATs) (2020-2028) ($MN)
Table 117 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Phenotypic Drug Susceptibility Tests (2020-2028) ($MN)
Table 118 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Adenosine Deaminase (ADA) Test (2020-2028) ($MN)
Table 119 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Type (2020-2028) ($MN)
Table 120 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Sputum Smear Microscopy (2020-2028) ($MN)
Table 121 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Rapid Molecular Diagnostics (2020-2028) ($MN)
Table 122 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Culture-based Diagnostics (2020-2028) ($MN)
Table 123 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Other Types (2020-2028) ($MN)
Table 124 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By End User (2020-2028) ($MN)
Table 125 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratories (2020-2028) ($MN)
Table 126 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Hospitals (2020-2028) ($MN)
Table 127 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Public (2020-2028) ($MN)
Table 128 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Private (2020-2028) ($MN)
Table 129 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Clinics (2020-2028) ($MN)
Table 130 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Reference Laboratories (2020-2028) ($MN)
Table 131 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Research Institutes and Academics (2020-2028) ($MN)
Table 132 Asia Pacific Tuberculosis (TB) Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 133 South America Tuberculosis (TB) Diagnostics Market Outlook, By Country (2020-2028) ($MN)
Table 134 South America Tuberculosis (TB) Diagnostics Market Outlook, By Product Types (2020-2028) ($MN)
Table 135 South America Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Latent Infection (2020-2028) ($MN)
Table 136 South America Tuberculosis (TB) Diagnostics Market Outlook, By Cytokine Detection Assay (2020-2028) ($MN)
Table 137 South America Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratory Methods (2020-2028) ($MN)
Table 138 South America Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Testing (2020-2028) ($MN)
Table 139 South America Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Drug Resistance (2020-2028) ($MN)
Table 140 South America Tuberculosis (TB) Diagnostics Market Outlook, By Radiographic Method (2020-2028) ($MN)
Table 141 South America Tuberculosis (TB) Diagnostics Market Outlook, By Other Products (2020-2028) ($MN)
Table 142 South America Tuberculosis (TB) Diagnostics Market Outlook, By Test Type (2020-2028) ($MN)
Table 143 South America Tuberculosis (TB) Diagnostics Market Outlook, By Tuberculin Skin Tests (2020-2028) ($MN)
Table 144 South America Tuberculosis (TB) Diagnostics Market Outlook, By Interferon-Gamma Release Assays (IGRAs) (2020-2028) ($MN)
Table 145 South America Tuberculosis (TB) Diagnostics Market Outlook, By Smear Microscopy (2020-2028) ($MN)
Table 146 South America Tuberculosis (TB) Diagnostics Market Outlook, By Serological Antibody-Based Tests (2020-2028) ($MN)
Table 147 South America Tuberculosis (TB) Diagnostics Market Outlook, By Culture (2020-2028) ($MN)
Table 148 South America Tuberculosis (TB) Diagnostics Market Outlook, By Identification or Speciation Tests (2020-2028) ($MN)
Table 149 South America Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Amplification Tests (NAATs) (2020-2028) ($MN)
Table 150 South America Tuberculosis (TB) Diagnostics Market Outlook, By Phenotypic Drug Susceptibility Tests (2020-2028) ($MN)
Table 151 South America Tuberculosis (TB) Diagnostics Market Outlook, By Adenosine Deaminase (ADA) Test (2020-2028) ($MN)
Table 152 South America Tuberculosis (TB) Diagnostics Market Outlook, By Type (2020-2028) ($MN)
Table 153 South America Tuberculosis (TB) Diagnostics Market Outlook, By Sputum Smear Microscopy (2020-2028) ($MN)
Table 154 South America Tuberculosis (TB) Diagnostics Market Outlook, By Rapid Molecular Diagnostics (2020-2028) ($MN)
Table 155 South America Tuberculosis (TB) Diagnostics Market Outlook, By Culture-based Diagnostics (2020-2028) ($MN)
Table 156 South America Tuberculosis (TB) Diagnostics Market Outlook, By Other Types (2020-2028) ($MN)
Table 157 South America Tuberculosis (TB) Diagnostics Market Outlook, By End User (2020-2028) ($MN)
Table 158 South America Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratories (2020-2028) ($MN)
Table 159 South America Tuberculosis (TB) Diagnostics Market Outlook, By Hospitals (2020-2028) ($MN)
Table 160 South America Tuberculosis (TB) Diagnostics Market Outlook, By Public (2020-2028) ($MN)
Table 161 South America Tuberculosis (TB) Diagnostics Market Outlook, By Private (2020-2028) ($MN)
Table 162 South America Tuberculosis (TB) Diagnostics Market Outlook, By Clinics (2020-2028) ($MN)
Table 163 South America Tuberculosis (TB) Diagnostics Market Outlook, By Reference Laboratories (2020-2028) ($MN)
Table 164 South America Tuberculosis (TB) Diagnostics Market Outlook, By Research Institutes and Academics (2020-2028) ($MN)
Table 165 South America Tuberculosis (TB) Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 166 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Country (2020-2028) ($MN)
Table 167 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Product Types (2020-2028) ($MN)
Table 168 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Latent Infection (2020-2028) ($MN)
Table 169 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Cytokine Detection Assay (2020-2028) ($MN)
Table 170 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratory Methods (2020-2028) ($MN)
Table 171 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Testing (2020-2028) ($MN)
Table 172 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Detection of Drug Resistance (2020-2028) ($MN)
Table 173 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Radiographic Method (2020-2028) ($MN)
Table 174 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Other Products (2020-2028) ($MN)
Table 175 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Test Type (2020-2028) ($MN)
Table 176 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Tuberculin Skin Tests (2020-2028) ($MN)
Table 177 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Interferon-Gamma Release Assays (IGRAs) (2020-2028) ($MN)
Table 178 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Smear Microscopy (2020-2028) ($MN)
Table 179 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Serological Antibody-Based Tests (2020-2028) ($MN)
Table 180 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Culture (2020-2028) ($MN)
Table 181 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Identification or Speciation Tests (2020-2028) ($MN)
Table 182 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Nucleic Acid Amplification Tests (NAATs) (2020-2028) ($MN)
Table 183 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Phenotypic Drug Susceptibility Tests (2020-2028) ($MN)
Table 184 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Adenosine Deaminase (ADA) Test (2020-2028) ($MN)
Table 185 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Type (2020-2028) ($MN)
Table 186 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Sputum Smear Microscopy (2020-2028) ($MN)
Table 187 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Rapid Molecular Diagnostics (2020-2028) ($MN)
Table 188 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Culture-based Diagnostics (2020-2028) ($MN)
Table 189 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Other Types (2020-2028) ($MN)
Table 190 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By End User (2020-2028) ($MN)
Table 191 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Diagnostic Laboratories (2020-2028) ($MN)
Table 192 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Hospitals (2020-2028) ($MN)
Table 193 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Public (2020-2028) ($MN)
Table 194 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Private (2020-2028) ($MN)
Table 195 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Clinics (2020-2028) ($MN)
Table 196 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Reference Laboratories (2020-2028) ($MN)
Table 197 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Research Institutes and Academics (2020-2028) ($MN)
Table 198 Middle East & Africa Tuberculosis (TB) Diagnostics Market Outlook, By Other End Users (2020-2028) ($MN)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 結核（TB）診断の世界市場予測（～2027年）(Tuberculosis (TB) Diagnostics Market Forecasts to 2028 – Global Analysis by Product Types (Detection of Latent Infection, Cytokine Detection Assay, Diagnostic Laboratory Methods, Other Product Types), Test Type (Tuberculin skin tests, Interferon-gamma release assays (IGRAs), Smear microscopy, Other test types), Type (Sputum Smear Microscopy, Rapid Molecular Diagnostics, Other Types), End-user (Diagnostic Laboratories, Hospitals, Other end users), and By Geography)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 結核（TB）診断のグローバル市場（～2027）：潜在感染検出、サイトカイン検出アッセイ、診断検査法、その他
  • 非侵襲的がん診断の世界市場予測（～2027年）
  • 血液型検査の世界市場予測（～2027年）
  • 分子診断の世界市場予測（～2030）
  • 結核（TB）診断の世界市場2022年～2029年：診断検査別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆